Revisión

Type 1 glucose transporter (Glut1) deficiency: manifestations of a hereditary neurological syndrome

J.M. Pascual, B. Lecumberri, D. Wang, R. Yang, K. Engelstad, D.C. De Vivo [REV NEUROL 2004;38:860-864] PMID: 15152356 DOI: https://doi.org/10.33588/rn.3809.2003609

OPEN ACCESS

Volumen 38 | Number 09 | Nº of views of the article 14.820 | Nº of PDF downloads 925 | Article publication date 01/05/2004

Download PDF Castellano Citation Search in PubMed

Share in:

Go to another issue

ABSTRACT

Aim. To define this genetic syndrome. DEVELOPMENT. The constellation of infantile epilepsy, acquired microcephaly and hypoglychorrachia is characteristic of Glucose transporter type 1 (Glut1) deficiency syndrome, a prototype neurometabolic disorder caused by inheritable mutations in the gene SLC2A1. All known mutations reduce the function of Glut1 in the blood brain barrier and thus limit brain glucose availability. As the cerebral metabolic rate for glucose increases during infancy, patients become gradually symptomatic, a phenomenon that underscores the importance of early diagnosis via lumbar puncture and treatment, which has meet with some success in ameliorating several -but not all- features of the disease. CONCLUSION. The increasing number of mild phenotypic variants being described, owing to the improved awareness of the disease, has led to the consideration of Glut1 deficiency in the diagnosis of infantile seizures, mental retardation, familial epilepsy and movement disorders. KeywordsBlood brain barrier Epilepsy Hypoglychorrachia Ketogenic diet Microcephaly CategoriesEpilepsias y síndromes epilépticos

FULL TEXT (solo disponible en lengua castellana / Only available in Spanish)

Acceso directo al último número

Último Podcast

Revisión

Type 1 glucose transporter (Glut1) deficiency: manifestations of a hereditary neurological syndrome